Catrine Johansson
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9.
Journal: Nature chemistry
Published: December 02, 2024
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 27, 2024
JmjC catalysed histone H2a N-methyl arginine demethylation and C4-arginine hydroxylation reveals importance of sequence-reactivity relationships.
Journal: Communications biology
Published: December 20, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal: Blood cancer journal
Published: February 06, 2023
The catalytic domains of all human KDM5 JmjC demethylases catalyse N-methyl arginine demethylation.
Journal: FEBS letters
Published: October 27, 2022
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal: Blood cancer journal
Published: October 04, 2022
Recognition of Dimethylarginine Analogues by Tandem Tudor Domain Protein Spindlin1.
Journal: Molecules (Basel, Switzerland)
Published: December 27, 2021
Editorial: Novel Strategies in Drug Development Against Multifactorial Diseases.
Journal: Frontiers in chemistry
Published: December 17, 2021
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance.
Journal: Nature communications
Published: December 11, 2021
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.
Journal: Journal of medicinal chemistry
Published: November 29, 2021
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.
Journal: Blood cancer discovery
Published: July 14, 2021
Last Updated: 09/26/2026